IQ Healthy Hearts ETF (HART)
| Assets | $6.93M |
| Expense Ratio | 0.45% |
| PE Ratio | 20.80 |
| Shares Out | 250,000 |
| Dividend (ttm) | $0.33 |
| Dividend Yield | 1.19% |
| Ex-Dividend Date | Mar 17, 2023 |
| Payout Ratio | 24.67% |
| 1-Year Return | +2.56% |
| Volume | 375 |
| Open | 28.14 |
| Previous Close | 27.76 |
| Day's Range | 28.14 - 28.14 |
| 52-Week Low | 24.00 |
| 52-Week High | 28.75 |
| Beta | 0.71 |
| Holdings | 81 |
| Inception Date | Jan 14, 2021 |
About HART
Fund Home PageThe IQ Healthy Hearts ETF (HART) is an exchange-traded fund that is based on the IQ Candriam Healthy Hearts index, a market-cap-weighted index composed of global stocks with favorable health-related ESG ratings. HART was launched on Jan 14, 2021 and is managed by IndexIQ.
Top 10 Holdings
54.84% of assets| Name | Symbol | Weight |
|---|---|---|
| Alphabet Inc. | GOOGL | 6.71% |
| Eli Lilly and Company | LLY | 6.49% |
| Apple Inc. | AAPL | 5.88% |
| Novo Nordisk A/S Class B | NOVO B.CO | 5.50% |
| Novartis AG Registered Shares | NOVN.SW | 5.40% |
| AstraZeneca PLC | AZN.L | 5.30% |
| Abbott Laboratories | ABT | 4.94% |
| UnitedHealth Group Incorporated | UNH | 4.89% |
| Merck & Co., Inc. | MRK | 4.89% |
| Johnson & Johnson | JNJ | 4.83% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 17, 2023 | $0.11657 | Mar 23, 2023 |
| Dec 16, 2022 | $0.06122 | Dec 22, 2022 |
| Sep 16, 2022 | $0.05658 | Sep 22, 2022 |
| Jun 17, 2022 | $0.09944 | Jun 24, 2022 |
| Mar 18, 2022 | $0.12123 | Mar 24, 2022 |
| Dec 20, 2021 | $0.03324 | Dec 27, 2021 |
News
Rising Pharma Prices Could Give a Beat to HART ETF
Data indicate that inflation is easing. Add to that, the Inflation Reduction Act, which passed last year, allows Medicare to negotiate prices on some popular drugs with pharmaceutical companies.
Healthcare Could Be a Healthy Sector Bet in 2023
The healthcare sector, the second-largest sector allocation in the S&P 500, performed significantly less poorly than the broader market in 2022 and that relative sturdiness has some market observers o...
Reliability Carried the Day for Healthcare Sector in 2022
With just two trading days left in 2022, it's safe to say the healthcare sector was significantly less bad than the broader market. As of December 27, the S&P 500 Health Care Index was down just 2.2% ...
HART Heavy on Healthcare Bounce Back Plays
With compelling long-term opportunities available across multiple industry groups, healthcare has the makings of a 2023 redemption, potentially boding well for exchange traded funds such as the IQ Hea...
Healthcare Could Be Healthy 2023 Sector Bet
The defensive healthcare sector is living up to its billing this year, as the S&P 500 Health Care Index is lower by just 0.72% compared to 15.37% for the S&P 500.
HART Helpful for Avoiding Healthcare ESG Issues
On the surface, healthcare appears to be a sector with obvious environmental, social, and governance (ESG) credentials, meaning it's not surprising the group is prominent in an array of ESG exchange t...
FDA Rebound Could Help HART Beat Higher
Experienced healthcare investors know that the Food & Drug Administration (FDA) often looms large. After all, that is the regulatory body that has the final say in whether or not biotechnology and pha...
HART Helpful Idea for Healthcare Defense
The healthcare sector is in the red this year, but its defensive traits are helping the group sharply outperform the broader market. That could be an encouraging sign for healthcare exchange traded fu...
Hone in on HART for Defensive Positioning
The healthcare sector is considered a defensive group, which should increase its allure in turbulent market climates, such as the current setting.
HART Beat to Practical Healthcare ETF
Investors looking to capitalize on the healthcare sector's defensive and quality traits while contributing to the greater good have an appealing idea thanks to the IQ Healthy Hearts ETF (HART). HART i...
HART ETF Living Up to Dual Impact Mission
Impact investing is garnering more attention, but it's often framed in terms of a style — not something that's applicable for funds to perform. However, it is possible for money managers to do right b...
HART Healthy With Attractively Valued Stocks
Broadly speaking, the healthcare sector, perhaps owing to its defensive properties, is seen as fairly valued. However, there are plenty of individual stocks within this group that are considered attra...
HART: A Beat on Unique Healthcare Investing
Investors can do good for the world at large while still profiting, and that effort isn't confined to environmental, social, and governance (ESG) strategies. Take the case of the IQ Healthy Hearts ETF...
How to Invest in Heart Research as COVID-19 Heart Impacts Increase
Study after study continues to be published on the ongoing aftereffects of people that have had COVID-19 as scientists and researchers race to better understand the virus that has infected over 83 mil...
Why Investment into Women's Heart Health is Desperately Needed
The American Heart Association's most recent Presidential Advisory addressed the large gap in research between men's heart health and women's. In a world where men's heart health has become the gold s...
This Pharmaceutical Company Is Growing — Here's How to Invest
Last week, Danish pharmaceutical company Novo Nordisk announced its first quarter earnings beating estimates, raising its growth outlook for the rest of 2022 and expanding its buyback program, reports...
What a Menthol Cigarette Ban Means for Heart Health
The Biden administration is expected to announce a regulatory plan today, April 28, that will culminate in a national ban of menthol cigarettes and all flavored cigarettes, a policy that has been two ...
Better Healthcare Really Does Lead to Longer Lives
Researchers from the Framington Heart Study, a multi-generational study that began in 1948, have found that men and women are living longer and incidents of heart disease are occurring later in life o...
How to Invest in Diversity, Heart Health, and Good Causes
Regulation concerning ESG metrics reported by countries and utilized by funds is in the works in the U.S. For now, however, regulation remains nonexistent as the SEC ponders how to apply a regulatory ...
Nearly Half of Americans Have Had Heart Issues Since Pandemic
Approximately 40% of Americans have experienced a heart-related issue since the onset of the COVID-19 pandemic, according to a study from the Cleveland Clinic. Lifestyle changes, stress, increased dri...
Healthcare Industry Set for Spectacular Innovation in Next Decade
The new CEO of Johnson & Johnson, Joaquin Duato, believes that healthcare will experience greater innovations in the next 10 years than it has over the entirety of the previous century, reports CNBC. ...
Investing in Heart Health as Pandemic Eases
The newest cycle of COVID-19 infections may finally signal a downshift to an endemic according to a leading epidemiologist, reports CNBC. Omicron BA.2 spreads 80% faster than Omicron and is on its way...
ETF of the Week: IQ Healthy Hearts ETF (HART)
ETF Trends' CEO Tom Lydon discusses the IQ Healthy Hearts ETF (HART) on this week's ETF of the Week podcast with Chuck Jaffe of the MoneyLife Show. Lydon explains that ESG has seen an explosion of int...
This ETF is designed to help fight heart disease while making you money. Here's how
It's an ETF looking to make you money while saving lives.
ETF Edge: Listen To Your HART ETF For Valentine's Day
It's American Heart Month, which is about raising awareness of the importance of vascular health. For “ETF Edge,” CNBC's Frank Holland gets into healthy heart investing via the IndexIQ Healthy Hearts ...